Avivomed

Avivomed

Developing and commercializing next generation neuromodulaton technology platforms to treat patients suffering from chronic diseases.

HQ location
Minneapolis, United States
Launch date
Employees
Enterprise value
$128—192m
  • Edit
loading funding rounds…
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads